Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05020678
Title NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nkarta Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Colorado Blood Cancer Institute RECRUITING Denver Colorado 80218 United States Details
University of Chicago WITHDRAWN Chicago Illinois 60637 United States Details
The Cleveland Clinic Foundation RECRUITING Cleveland Ohio 44195 United States Details
Institute of Haematology, Royal Prince Alfred Hospital RECRUITING Camperdown New South Wales 2050 Australia Details
St. Vincent's Hospital RECRUITING Sydney New South Wales 2010 Australia Details
Royal Brisbane and Woman's Hospital RECRUITING Brisbane Queensland 4029 Australia Details
Peter MacCallum Cancer Center RECRUITING Melbourne Victoria 3000 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field